Dubai-based tokenization platform Allo has secured a $100 million financing backed by Bitcoin. According to a Dec. 19 ...

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its holdings in shares of Allogene Therapeutics, ...

Allogene Therapeutics Inc (ALLO) stock saw a modest uptick, ending the day at $2.27 which represents a slight increase of $0.08 or 3.65% from the prior close of $2.19. The stock opened at $2.21 and ...

Allogene Therapeutics (ALLO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates ...

Allo Fiber received the Lincoln Chamber of Commerce’s top business award during an awards ceremony on Wednesday.

Piper Sandler analyst Biren Amin maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report) today and set a price target of ...

Transplant is beneficial earlier in life, Wang told MedPage Today, but carries potential short- and long-term side effects.

SER-155 is an oral, 16-strain microbiome therapeutic that works by decolonizing gastrointestinal pathogens, strengthening the epithelial barrier, and inducing immune tolerance.

EMA approves blinded, multi-centric Phase-3 trial ( NCT06489028) to investigate the safety and efficacy of allo-APZ2-CVU in ...

金色财经报道，迪拜代币化平台Allo宣布获得1亿美元比特币支持的信贷额度，融资由Greengage及一家“长期运营的美国机构”提供。这笔资金将用于扩展链上借贷和实物资产代币化服务。

Socioeconomic factors significantly impact access to allogeneic hematopoietic stem cell transplant in patients with acute ...

Dubai-based tokenization platform Allo has secured a $100 million financing backed by Bitcoin (BTC). According to a Dec. 19 announcement, the credit line was funded by a consortium of lenders ...